Bassetti, S., & Battegay, M. (2004). Staphylococcus aureus infections in injection drug users: Risk factors and prevention strategies. Infection, 32, 163-169.
Cohen, A., Shuler, C., McAllister, S., Fosheim, G., Brown, M., Abercrombie, D., . . . Gorwitz, R. (2007). Methamphetamine use and methicillin-resistant Staphylococcus aureus skin infections. Emerging Infectious Diseases, 13(11), 1707-1713.
Dahlman, D., Hakansson, A., Bjorkman, P., Blome, M., & Kral, A. (2015). Correlates of skin and soft tissue infections in injection drug users in syringe-exchange program in Malmo, Sweden. Substance Use and Misuse, 50(12), 1529-1535.
Des Jarlais, D., Nugent, A., Solberg, A., Feelemyer, J., Mermin, J., & Holtzman, D. (2015). Syringe service programs for persons who inject drugs in urban, suburban, and rural areas - United States, 2013. MMWR Morbidity and Mortality Weekly Report, 64(48), 1337-1341.
Ebright, J., & Pieper, B. (2002). Skin and soft tissue infections in injection drug users. Infectious Disease Clinics of North America, 16(3), 697-712.
Ghertner, R., & Groves, L. (2018, September 11). The opioid crisis and economic opportunity: Geographic and economic trends. U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning.
Gray, M., Rogawaski McQuade, E., Scheld, W., & Dillingham, R. (2018, October 24). Rising rates of injection drug use associated infective endocarditis in Virginia with missed opportunities for addiction treatment referral: a retrospective cohort study. BMC Infect Dis, 18(1), 532.
Hartnett, K., Jackson, K., Felsen, C., McDonald, R., Bardossy, A., Gokhale, R., . . . Dumyati, G. (2019). Bacterial and fungal infections in persons who inject drugs - Western New York, 2017. MMWR Morb Mortal Wkly Rep, 68(26), 582-586.
Heckathorn, D. (1997, May 1). Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems, 44(2), 174-199.
Hope, V., Kimber, J., Vickerman, P., Hickman, M., & Ncube F. (2008, September 18). Frequency, factors and costs associated with injection site infections: Findings from a national multi-site survey of injecting drug users in England. BMC Infectious Diseases, 8, 120.
Hope, V., Marongiu, A., Parry, J., & Ncube, F. (2010, October). The extent of injection site infection in injecting drug users: Findings from a national surveillance study. Epidemiology & Infection, 138(10), 1510-1518.
Lavendar, T., & McCarron, B. (2013). Acute infections in intravenous drug users. Clinical Medicine (London), 13(5), 511-513.
McCarthy, N., Baggs, J., See, I., Reddy, S., Jernigan, J., Gokhale, R., & Fiore, A. (2020, October 23). Bacterial infections associated with substance use disorders, large cohort of United States hospitals, 2012-2017. Clinical Infectious Diseases, 71(7), e37-e44.
Monteiro, J., Phillips, K., Herman, D., Stewart, C., Keosaian, J., Anderson, B., & Stein, M. (2020, January 1). Self-treatment of skin infections by people who inject drugs. Drug and Alcohol Dependence, 206, 107695.
Murphy, E., DeVita, D., Liu, H., Vittinghoff, E., Leung, P., Ciccarone, D., & Edlin, B. (2001, July 1). Risk factors for skin and soft-tissue abscesses among injection drug users: A case-control study. Clinical Infectious Disease, 33(1), 35-40.
Nenninger, E., Carwile, J., Ahrena, K., Armstrong, B., & Thakarar, K. (2020, February 21). Rural-urban differences in hospitalizations for opioid use-associated infective endocarditis in the United States. Open Forum Infectious Diseases, 7(2), ofaa045.
Otiashyili, D., Latypov, A., Kirtadze, I., Ibragimov, U., & Zule, W. (2016, June 2). Drug preparation, injection, and sharing practices in Tajikistan: A qualitative study in Kulob and Khorog. Substance Abuse Treatment, Prevention, and Policy, 11(1), 21.
Page, K., Morris, M., Hahn, J., Maher, L., & Prins, M. (2013). Injection drug use and Heptatitis C Virus in young adult injectors: Using evidence to inform comprehensive prevention. Clinical Infectious Diseases, 57(Suppl 2), S32-S38.
Persons who inject drugs (PWID). (2018).
Phillips, K., & Stein, M. (2010, March). Risk practices associated with bacterial infections among injection drug users in Denver, Colorado. The American Journal of Drug and Alcohol Abuse, 36(2), 92-97.
Phillips, K., Anderson, B., Herman, D., Liebschutz, J., & Stein, M. (2017). Risk factors associated with skin and soft tissue infections among hospitalized people who inject drugs. Journal of Addiction Medicine, 11(6), 461-467.
(2019). Poverty fact sheet: Wisconsin's opioid crisis. University of Wisconsin - Madison, Institute for Research on Poverty.
Salamanca, S., Sorrentino, E., Nosanchuk, J., & Martinez, L. (2014, January 12). Impact of methamphetamine on infection and immunity. Frontiers in Neuroscience, 8, 445.
Smith, M., Robinowitz, N., Chaulk, P., & Johnson, K. (2016). High rates of abscesses and chronic wounds in community-recruited injection drug users and associated risk factors. Journal of Addiction Medicine, 9(2), 87-93.
Strickland, J., Havens, J., & Stoops, W. (2019, November 1). A national representative analysis of "twin epidemics": Rising rates of methamphetamine use among persons who use opioids. Journal of Drug and Alcohol Dependence, 204, 107592.
Takahashi, T., Maciewjewski, M., & Bradley, K. (2010, October). US hospitalizations and costs for illicit drug users with soft tissue infections. The Journal of Behavior Health Services and Research, 37(4), 508-518.
Tuchman, E. (2015). Women's injection drug practices in their own words: A qualitative study. Harm Reduction Journal, 12(6).
Twillman, R., Dawson, E., LaRue, L., Guevara, M., Whitley, P., & Huskey, A. (2020, January 3). Evaluation of trends of near-real-time urine drug test results for methamphetamine, cocaine, heroin, and fentanyl. JAMA Network Open, e1918514.
Weisgrau, S. (1995). Issues in rural health: Access, hospitals, and reform. Health Care Financing Review, 17(1), 1-14.